INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,558 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
AB
Alves Sandra Isabelle BarrosSVP, Finance and CAO
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
31.6K sh
Jan 28, 2026
Page 1416 of 1814
← PrevNext →
Jan 28, 2026
traded Jan 28, 2026
+0d
SEC Form 4

Evidence

9
SL
Simonelli LorenzoDirector, Chairman, President and CEO
BKRBaker Hughes Co
Option exercise
M—
50.9K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
GD
Giles Jeffrey DEVP, Corporate Development
CNMCore & Main, Inc.
Grant or award
A—
10.6K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
CM
Cavellier James M JrCIO
CASSCASS INFORMATION SYSTEMS INC
Tax withholding
F$29K
647 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
WA
Winn Caroline AnnExecutive Vice President
SRESEMPRA
Grant or award
A—
2,623 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
GV
Geraci VincentDirector Mortgage Lending/FSVP
UNTYUNITY BANCORP INC /NJ/
Tax withholding
F$17K
316 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
SJ
Scheiwer Mark JEVP, CFO & CAO
SMGSCOTTS MIRACLE-GRO CO
Grant or award
A$650
10 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
MJ
Melloh Heather J.EVP AND GENERAL COUNSEL
AMPAMERIPRISE FINANCIAL INC
Tax withholding
F$21K
42 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
MJ
McClintock Douglas JSEVP
FFICFLUSHING FINANCIAL CORP
Option exercise
M—
2,000 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
ED
Erdbruegger Dwight DPresident
CASSCASS INFORMATION SYSTEMS INC
Tax withholding
F$28K
635 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
AI
Asner Scott IanDirector
NONENONEFERRELLGAS PARTNERS L P
Grant or award
A—
3,796 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Option exercise
M—
20.1K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
BR
Benante Martin RDirector
CRCrane Co
Grant or award
A—
44 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
BM
Brockman Dawn M.SVP AND CONTROLLER
AMPAMERIPRISE FINANCIAL INC
Tax withholding
F$11K
22 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
LE
Lee David EricVICE CHAIR, WINTRUST FINANCIAL
WTFCWINTRUST FINANCIAL CORP
Tax withholding
F$31K
215 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
SS
Schuckman Matthew StevenExecutive Vice President
CASSCASS INFORMATION SYSTEMS INC
Tax withholding
F$24K
548 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
MN
Mac Ban Ryan NorrisChief Revenue Officer
CFLTConfluent, Inc.
Grant or award
A—
59.9K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
SR
Simantov RonitDirector
TPSTTempest Therapeutics, Inc.
Grant or award
A—
1,230 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
AA
Alcala AlejandroExec. V.P. & Chief Op. Officer
CRCrane Co
Option exercise
M—
3,133 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
MG
Magno Maria GeorgiaChief Legal Officer
BKRBaker Hughes Co
Option exercise
M—
2,654 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
SR
Schroer John R.Chief Financial Officer
ALMSALUMIS INC.
Grant or award
A—
202.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
FS
Forte SteveEVP, CHIEF FINANCIAL OFFICER
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
500.0K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC Form 4

Evidence

9
EW
Eifler Robert W.Director, President & CEO
NENoble Corp plc
Option exercise
M—
17.0K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
JE
Jewell Curtis ESVP, General Counsel
ESABESAB Corp
Option exercise
M—
3,960 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
FS
Forte SteveEVP, CHIEF FINANCIAL OFFICER
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
325.8K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC Form 4

Evidence

9
FS
Forte SteveEVP, CHIEF FINANCIAL OFFICER
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
85.0K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC Form 4

Evidence

9
AB
Alves Sandra Isabelle BarrosSVP, Finance and CAO
RPTXRepare Therapeutics Inc.
Disposition to issuer
D—
26.0K sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC Form 4

Evidence

9
FS
Filer Matthew SSVP Finance / CAO
PATKPATRICK INDUSTRIES INC
Tax withholding
F$37K
287 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
HJ
Hofmeister Brandon J.Senior Vice President
CMSCMS ENERGY CORP
Grant or award
A—
326 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
DW
Davies WilliamEXECUTIVE VP, GLOBAL CIO
AMPAMERIPRISE FINANCIAL INC
Disposition to issuer
D$49K
98 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
BL
Berry Tonya LExecutive Vice President & COO
CMSCMS ENERGY CORP
Grant or award
A—
230 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
AG
Alvero GumerPRESIDENT-INSURANCE&ANNUITIES
AMPAMERIPRISE FINANCIAL INC
Tax withholding
F$20K
40 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

9
AG
Alvero GumerPRESIDENT-INSURANCE&ANNUITIES
AMPAMERIPRISE FINANCIAL INC
Tax withholding
F$18K
36 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

9
PS
Pangali SanamChief Legal Officer
ALMSALUMIS INC.
Grant or award
A—
186.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

8
LL
Larroque Alexander LisaSVP, Corp Affairs and HR
SRESEMPRA
Tax withholding
F$50K
577 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

8
SL
Sedgwick Karen LExecutive VP and CFO
SRESEMPRA
Tax withholding
F$155K
1,783 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

8
WA
Winn Caroline AnnExecutive Vice President
SRESEMPRA
Tax withholding
F$137K
1,575 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

7
FS
Fendley Steven S.President, US Division
KTOSKRATOS DEFENSE & SECURITY SOLUTIONS, INC.
Open-market sale · 10b5-1 plan
SELL$318K
2,968 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

7
FS
Fendley Steven S.President, US Division
KTOSKRATOS DEFENSE & SECURITY SOLUTIONS, INC.
Open-market sale · 10b5-1 plan
SELL$437K
4,032 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

7
AK
Adamson KeelanDirector, PRESIDENT AND CEO
RIGTransocean Ltd.
Open-market sale · 10b5-1 plan
SELL$293K
58.7K sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence